Jove
Visualize
Contact Us

Related Experiment Videos

Vigabatrin in pediatric epilepsy--an open study.

P Uldall1, J Alving, L Gram

  • 1Dianalund Epilepsy Hospital, Denmark.

Journal of Child Neurology
|January 1, 1991
PubMed
Summary

Vigabatrin effectively reduced seizure frequency in children with severe epilepsy, with over half experiencing significant improvement. While some seizures recurred, they were less frequent, and the drug was generally well-tolerated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ictal and interictal electric source imaging in pre-surgical evaluation: a prospective study.

European journal of neurology·2018
Same author

Risk of impaired cognition after prenatal exposure to psychotropic drugs.

Acta psychiatrica Scandinavica·2017
Same author

Comparative assessment of Vibrio virulence in marine fish larvae.

Journal of fish diseases·2017
Same author

Biofilm formation is not a prerequisite for production of the antibacterial compound tropodithietic acid in Phaeobacter inhibens DSM17395.

Journal of applied microbiology·2014
Same author

Control of bacterial disease in cultures of marine larvae and live feed organisms by a probiotic bacterium.

Communications in agricultural and applied biological sciences·2014
Same author

Trends in Anti-epileptic Drug Development.

Behavioural neurology·2014
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Epileptology

Background:

  • Limited data exists on vigabatrin's long-term efficacy and safety in pediatric epilepsy.
  • Adult studies confirm vigabatrin's antiepileptic effects.

Purpose of the Study:

  • To evaluate the long-term effect and safety of vigabatrin as an add-on therapy in children with severe epilepsy.
  • To assess the dose-ranging effects of vigabatrin in this population.

Main Methods:

  • An open-label, add-on, dose-ranging study.
  • Enrolled children with various epilepsy types, including partial epilepsy, generalized epilepsy, and Lennox-Gastaut syndrome.
  • Monitored seizure frequency, adverse events, and physiologic effects.

Main Results:

  • 54% of pediatric patients achieved >50% reduction in seizure frequency; 4 became seizure-free.
  • Significant seizure reduction observed across the patient cohort, with recurrence at lower frequencies.
  • 39% of patients reported adverse events; no significant impact on growth or physical examination.

Conclusions:

  • Vigabatrin demonstrates significant long-term efficacy in reducing seizure frequency in children with severe epilepsy.
  • The drug is generally well-tolerated in pediatric patients, with manageable adverse events.
  • Further investigation into specific epilepsy syndromes may be warranted.

Related Experiment Videos